Humacyte
Mr. Scheessele is a commercial leader with over 20 years of experience creating and growing businesses in the vascular and regenerative medicine markets. He is responsible for providing leadership, direction, and strategic vision to drive the commercial launch of the HAV in its initial vascular indications and follow-on market expansion.
This person is not in any offices
Humacyte
1 followers
Humacyte, Inc., is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.